Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 1, 2005, Pages 224-227

  Bouchillon, Sam K ^a   Johnson, Jack L ^a   Hoban, Daryl J ^a   Stevens, Tim M ^a   Johnson, Brian M ^a  

^a Labs Intl for Microbiology Studies   (United States)

Author keywords

H. influenzae; Ketolides; S. pneumoniae; S. pyogenes; Susceptibility testing

Indexed keywords

AZITHROMYCIN; CARBON DIOXIDE; TELITHROMYCIN; ANTIINFECTIVE AGENT; KETOLIDE;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; HAEMOPHILUS INFLUENZAE; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CARBON DIOXIDE; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 24044524528     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki156     Document Type: Article

References (10)

1. Brown SD, Rybak MJ. Antimicrobial susceptibility of [i#Streptococcus pneumoniae, Streptococcus pyogenes#1i] and [i#Haemophilus influenzae#1i] collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. [i#J Antimicrob Chemother#1i] 2004; [b#54#1b]: [i#Suppl 1#1i], I7-I15.
2. Clinical and Laboratory Standards Institute (CLSI). [i#Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters: Approved Guidelines - Second Edition: Document M23-A2#1i]. Wayne, PA, USA: CLSI, 2001.
3. Clinical and Laboratory Standards Institute (CLSI). [i#Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard - Sixth Edition: Document M7-A6#1i]. Wayne, PA, USA: CLSI, 2003.
4. Hunt Gerardo S, Citron DM, Claros MC [i#et al.#1i] Comparison of Etest to broth microdilution method for testing [i#Streptococcus pneumoniae#1i] susceptibility to levofloxacin and three macrolides. [i#Antimicrob Agents Chemother#1i] 1996; [b#40#1b]: 2413-5.
5. Johnson J, Bouchillon S, Pontani D. The effect of carbon dioxide on susceptibility testing of azithromycin, clarithromycin and roxithromycin against clinical isolates of [i#Streptococcus pneumoniae#1i] and [i#Streptococcus pyogenes#1i] by broth microdilution and the Etest: Artemis Project - first-phase study. [i#Clin Microbiol Infect#1i] 1995; [b#5#1b]: 327-30.
6. Johnson MM, Hill SL, Piddock LJ. Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. [i#Antimicrob Agents Chemother#1i] 1999; [b#43#1b]: 1862-5.
7. Biodisk AB. [i#Etest Technical Guide 5C. Etest for MIC Determination - Document M0000282#1i]. AB Biodisk, Solna, Sweden, 2000.
8. Bemer-Melchior P, Juvin ME, Tassin S [i#et al.#1i] In vitro activity of the new ketolide telithromycin compared with those of macrolides against [i#Streptococcus pyogenes#1i]: Influences of resistance mechanisms and methodological factors. [i#Antimicrob Agents Chemother#1i] 2000; [b#44#1b] 2999-3002.
9. Walsh F, Carnegy F, Willcock J [i#et al.#1i] Comparative [i#in vitro#1i] activity of telithromycin against macrolide-resistant and -susceptible [i#Streptococcus pneumoniae, Moraxella catarrhalis#1i] and [i#Haemophilus influenzae. J Antimicrob Chemother#1i] 2004; [b#53#1b]: 793-6.
10. Clinical and Laboratory Standards Institute (CLSI). [i#Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth Informational Supplement: Document M100-S15#1i]. Wayne, PA, USA: CLSI, 2004.